J. Lufkin

发表

Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study

L. Kwong, A. Kivitz, A. Çinar, 2021, Drugs in R&D.

A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis

L. Kwong, A. Kivitz, A. Çinar, 2022, Rheumatology and Therapy.

Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study

S. Russell, P. Conaghan, A. Kivitz, 2018, Rheumatology.

A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis

L. Kwong, A. Kivitz, A. Çinar, 2019, Therapeutic advances in musculoskeletal disease.

Synovial and systemic pharmacokinetics of triamcinolone acetonide following intra-articular injection of an extended release formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis

A. Kivitz, N. Bodick, J. R. Johnson, 2017 .

Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis

P. Conaghan, A. Kivitz, Joseph J. Ruane, 2019, Advances in Therapy.

An open-label phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced non-small cell lung cancer (NSCLC).

M. Socinski, G. Shapiro, R. Blackman, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study

C. Peterfy, J. Richmond, K. Huffman, 2019, Rheumatology and Therapy.

Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain

D. Jevsevar, D. Hunter, F. Berenbaum, 2018, The Journal of bone and joint surgery. American volume.

Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma.

A. Hauschild, S. Ugurel, W. Guo, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).

P. Conaghan, V. Kraus, A. Kivitz, 2018, Osteoarthritis and cartilage.

Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis.

P. Tak, S. Krausz, D. Gerlag, 2012, Arthritis and rheumatism.

Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

F. Berenbaum, P. Conaghan, N. Bodick, 2017, Arthritis & rheumatology.

An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials

V. Strand, D. Hunter, F. Berenbaum, 2017 .

An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.

D. Hunter, J. Bolognese, N. Bodick, 2015, The Journal of bone and joint surgery. American volume.

Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials

P. Conaghan, A. Kivitz, A. Çinar, 2019, Pain and Therapy.

1230 POSTER A Phase 1 and Pharmacokinetic Study of Ganetespib (STA-9090), a Heat Shock Protein 90 Inhibitor, in Combination With Docetaxel in Subjects With Advanced Solid Tumour Malignancies

F. Khuri, T. Owonikoko, S. Ramalingam, 2011 .

Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales

D. Turk, E. Ross, P. Conaghan, 2021, Pain and Therapy.

Safety and efficacy of FX006 in patients with osteoarthritis of the knee

D. Hunter, J. Bolognese, N. Bodick, 2014 .

Triamcinolone acetonide extended-release injectable suspension (TA-ER) is associated with reduced blood glucose elevation vs. standard triamcinolone in type 2 diabetes mellitus patients with knee osteoarthritis: a randomized, blinded, parallel-group study

P. Conaghan, A. Kivitz, G. Habib, 2018 .

FX006 prolongs the residency of triamcinolone acetonide in the synovial tissues of patients with knee osteoarthritis

C. Inderjeeth, N. Bodick, C. Willwerth, 2013 .